Alkermes Announces Results From Phase 2 Study Of ALKS 37 For Treatment Of Opioid-Induced Constipation
Alkermes plc today announced topline results from a phase 2b dose-ranging clinical study of ALKS 37 in the treatment of opioid-induced constipation. The multicenter, randomized, double-blind, placebo-controlled, repeat-dose study was designed to assess the safety, tolerability, pharmacokinetic profile and efficacy of ALKS 37 in approximately 150 patients. … Read News

THE NEW EFFECTIVE PROGRAM FOR GETTING PERSONS WITH ADDICTION …
GETTING PERSONS WITH ADDICTION INTO TREATMENT D o you love someone who is This event is in recognition of National Alcohol and Drug Addiction Recovery Alexandria Mental Health Center and the Partnership for a Healthier … Doc Retrieval    Read more...